Profile
NTRB VRTX REGN SGEN ALNY ARGX
Company Name Nutriband Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $86.11M $116.96B $58.10B $43.15B $41.50B $33.28B
Employees 0.01K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Mr. Gareth Sheridan Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
NTRB VRTX REGN SGEN ALNY ARGX
Quant Rating Score 1 2 4 3 1 2
Quant Rating Strong Sell Sell Buy Neutral Strong Sell Sell
Trading
NTRB VRTX REGN SGEN ALNY ARGX
Last Close $9.91 $459.62 $547.36 $228.74 $331.91 $543.48
High 52 $10.72 $516.74 $1201.76 $228.74 $331.91 $671.75
Low 52 $3.84 $396.64 $482.92 $228.74 $224.58 $435.84
Price vs. 52 Week High -7.56 % -11.05 % -54.45 % 0 % 0 % -19.09 %
Price vs. 52 Week Low 158.07 % 15.88 % 13.34 % 0 % 47.79 % 24.7 %
Total Return
NTRB VRTX REGN SGEN ALNY ARGX
1 Month Return 28.7 % 2.02 % 10.98 % 0 % 10.33 % -7.24 %
3 Month Return 83.52 % -3.16 % -4.55 % 0 % 40.79 % -2.1 %
6 Month Return 103.91 % 14.19 % -23.58 % 0 % 42.36 % -15.79 %
9 Month Return 65.17 % 0.95 % -45.96 % 0 % 23.85 % 2.55 %
YTD Return 110.4 % 14.13 % -23.16 % 0 % 41.05 % -11.63 %
1 Year Return 69.4 % -3.15 % -47.08 % 0 % 32.22 % 24.7 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NTRB VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -59.76 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
NTRB VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 32.88 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -162.11 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -113.25 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -118.88 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 160.49 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -259.09 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -1816.28 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM 25.48 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 2.23 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM 7.48 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 316.8 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 38.99 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -0.46 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -0.47 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 26.64 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -213.89 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.67 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -1816.28 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -16.51 -92.97 19.24 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -16.74 -119.36 14.77 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -16.74 -119.36 14.77 -93.1 -914.84 -515.98
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.8
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.89
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0222
ABSI Absci Corporation 2.77
ABUS Arbutus Biopharma Corporation 3.24
ABVC ABVC BioPharma, Inc. 3.11
ABVX Abivax SA American Depositary Shares 7.96
ACAD ACADIA Pharmaceuticals Inc. 20.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.607
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.18
ACIU AC Immune SA 2.07
ETFs With Exposure to NTRB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 308.03
VXF Vanguard Extended Market Index Fund 0.00043 197.5
IWC iShares Micro-Cap ETF 0.00549 133.14
VTSAX Vanguard Total Stock Market Index Fund 0 150.01
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00043 149.82
VITSX Vanguard Total Stock Market Index Fund 0 150.04
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00043 149.83
VEMPX Vanguard Extended Market Index InstlPlus 0.00043 369.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 281.45
Unlock